-

fact sheet

PhRMA Comment: Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products

PhRMA's comments in response to FDA’s notification of public hearing about manufacturer communications regarding unapproved uses of approved or cleared medical products (“FDA hearing notice”) and FDA’s Memorandum titled “Public Health Interests and First Amendment Considerations Related to Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products” (the “First Amendment Memorandum”).